Skip to main content

Section Editor

Lindsay C. Strowd, MD
Wake Forest School of Medicine
Winston-Salem, NC

Atopic Dermatitis

Atopic Dermatitis

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices
News
Findings from a small study conducted in China suggest topical ozone therapy has beneficial effects on the microbiome and could be used to treat atopic dermatitis.
Derm Q&A
Findings from a recent study showed patients with chronic inflammatory skin diseases had an increased risk for herpes zoster. Jonathan I. Silverberg, MD, PhD, MPH, discussed these findings with The Dermatologist.
NEA Approved Features
Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.
Voices
Children with eczema and their parents are often at wits’ end with alleviating the itch associated with atopic dermatitis. Perhaps it is time to shift the paradigm from “stop scratching” to alternative or behavioral health approaches to fight itch with less mental anguish.
Aesthetics Corner
Patients who present with atopic dermatitis often desire treatment of associated cosmetic concerns. Dermatologists should familiarize themselves with these tools for treating skin pigmentary and texture changes.   
NEA Approved Features
Diagnosis of atopic dermatitis in skin of color and in various age groups can be challenging. Understanding the differences in presentation can help with implementing appropriate treatment sooner.
Derm Q&A
In an interview with The Dermatologist, Andrew F. Alexis, MD, reviewed important considerations for diagnosing and treating atopic dermatitis in patients with skin of color.
Derm Q&A
A recent study showed that gluten was not associated with an increased risk for developing inflammatory skin diseases. Corresponding author Aaron Drucker, MD, discusses these findings with The Dermatologist.

NEA Approved Features
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
News
New research is illuminating the phenotypes of atopic dermatitis (AD) among racial subgroups, which could impact the efficacy of current and future therapies. In a recent study, researchers investigated the efficacy and safety of dupilumab among various racial subgroups.
Back to Top